Brexit At The 11th Hour: UK Refreshes No-Deal Guidance For Medtech
With the UK still wallowing in uncertainty over Brexit, the government has been forced hit the ground running in January by issuing various documents spelling out in greater detail what will need to happen in the case of a "no-deal" Brexit, which is looking increasingly possible. What does medtech need to know?
You may also be interested in...
The UK government is introducing new registration requirements for medical devices in the event of a no-deal Brexit. They will be rolled out according to the risk class of products. But some fundamental questions have arisen.
The UK’s 2019 medtech regulations laid in Parliament last week in preparation for a possible no-deal Brexit at the end of March are long and difficult to read. Medtech Insight spoke to the Medicines and Healthcare products Regulatory Agency to find out the essentials.
While it was obvious to those in the sector that the implementation of the EU IVD Regulation was heading for a disaster, this article looks at the facts and figures that helped sway the European Commission to propose new transition periods to better manage its implementation.